The epidemiology of anxiety disorders: prevalence and societal costs.
about
Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey ReplicationA systematic review and meta-analysis on controlled treatment trials of metacognitive therapy for anxiety disordersCritical review of outcome research on interpersonal psychotherapy for anxiety disordersDynorphin Controls the Gain of an Amygdalar Anxiety CircuitNeuro-stimulation Techniques for the Management of Anxiety Disorders: An UpdateLoop diuretics have anxiolytic effects in rat models of conditioned anxietyDoes D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool.Anxiety levels among Turkish public transportation drivers: a relation to restless legs syndrome?Anxiety symptoms among Chinese nurses and the associated factors: a cross sectional study.Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project.Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?Clinical and subthreshold panic disorder.A Web-based screening instrument for depression and anxiety disorders in primary care.The relation between past exposure to fine particulate air pollution and prevalent anxiety: observational cohort study.Interpersonal stress regulation and the development of anxiety disorders: an attachment-based developmental frameworkRates of detection of mood and anxiety disorders in primary care: a descriptive, cross-sectional study.A Study on Correlation between Anxiety Symptoms and Suicidal Ideation.Prevalence of anxiety disorders: a population-based epidemiological study in metropolitan area of Casablanca, Morocco.Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.An investigation of general predictors for cognitive-behavioural therapy outcome for anxiety disorders in a routine clinical setting.Collaborative care for anxiety disorders in primary care: a systematic review and meta-analysis.Olfactory Stimuli Increase Presence in Virtual Environments.Models and Methods to Investigate Acute Stress Responses in CattleDiagnosis and Treatment Procedures for Patients With Anxiety Disorders by the Psychiatric Consultation Liaison Service in a General Hospital in Germany: A Retrospective AnalysisGender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).Meta-analysis of the prevalence of anxiety disorders in mainland China from 2000 to 2015.Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Anxiety Increases After Zinc Therapy.Decreased zinc and increased copper in individuals with anxiety.Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.Anxiety and alcohol use disorders: comorbidity and treatment considerations.Oxidative stress and anxiety: relationship and cellular pathways.Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics studyCross-generational influences on childhood anxiety disorders: pathways and mechanisms.Acupuncture for Treating Anxiety and Depression in Women: A Clinical Systematic Review.Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial.
P2860
Q21143741-56F2E556-F4B4-4466-96E9-A2DF0A98537EQ24632666-3CA083B6-5A0E-4ABF-AD12-EE55BC0801B3Q26772189-86A83E16-F39A-49BF-BB1D-6AA907A81A47Q27011686-C5E3C5AF-CD12-41DC-8637-754FE4E904B9Q27319741-90944AF6-C3F9-4A61-BA05-6893C99B794DQ28069694-BEC3C305-3512-4F23-97B4-1F5E3E44580DQ28482301-4EBD54A9-14F5-4417-B6CE-57BC75ECCB64Q31171981-3EEA5F26-CF33-45BA-893D-14D158749E86Q33638578-FC71E9C9-3FED-4114-BB0E-853AE1A4D6C5Q33698731-6B7BC869-A362-467E-BAC7-9F381746B3DAQ33911121-DC2BFE01-A872-4934-A5B1-1A8C02BD7A57Q34414779-30BA5343-D2D1-46C6-A25D-5996A064E559Q34516239-A8902FC9-F62A-4CAF-B22A-5D4697220582Q34722479-58DAE0DD-A984-40CF-9E13-B18AAA7B34CDQ34981522-11E6A7A5-9057-4E53-A09D-B83E71A5C201Q34998078-602264AA-F241-4E24-A24D-73EEC30FA7CFQ35216683-97B96A26-1377-4AF5-A339-53430F0ED014Q35224058-39F7CA69-5A56-4DB0-A694-9D0E51D775BDQ35252125-0B8D810C-B02A-4ACF-9090-9FE22AE2473AQ35634302-11F4E7FF-829D-492A-BEF3-447ED6C96069Q35645838-70BD68F0-EF2B-4083-A3A1-855AE9AB0111Q35844079-18604EE1-86FA-4BE9-9EEB-279D732083EEQ35970773-03E854CD-8FCA-4AE5-B1B2-8D873C806E9DQ36036877-DE6643C0-1288-4CB7-9A29-8DB941AABAF0Q36054238-1502ADE2-02D4-41CF-9437-396A24A03240Q36409498-E60592EA-90B8-47AF-B49F-073004520A1EQ36518659-5728C797-039B-47CC-8D09-84467F4BA029Q36612447-D4079220-7BCA-4FC7-B880-B71908A2A4EAQ37010514-CA6A4377-45A0-4ED4-ADDF-59B6D694DFA0Q37078910-E07E4F3E-6694-407E-9B9D-337FC6F0BAD0Q37082779-22D577E7-E731-41C9-BD1D-1A0634571D66Q37248330-4073C286-8A59-4DD7-89FF-70605346C416Q37386367-43C9248B-76AA-4475-AFBC-D69BFA42757CQ37390287-80B44ACB-EF0F-4432-8AC8-E268E7B976B4Q37681855-0D66AD03-D283-48E9-A275-A2528685490EQ38825572-ADE35196-86A7-4220-AACB-2C5CE82179FDQ43119512-6AB3E305-F41C-4D5C-AD00-6C57A9E48291Q47148416-B06D4A86-7245-41FB-AF10-7C0F86EE2AEE
P2860
The epidemiology of anxiety disorders: prevalence and societal costs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
The epidemiology of anxiety disorders: prevalence and societal costs.
@ast
The epidemiology of anxiety disorders: prevalence and societal costs.
@en
type
label
The epidemiology of anxiety disorders: prevalence and societal costs.
@ast
The epidemiology of anxiety disorders: prevalence and societal costs.
@en
prefLabel
The epidemiology of anxiety disorders: prevalence and societal costs.
@ast
The epidemiology of anxiety disorders: prevalence and societal costs.
@en
P1476
The epidemiology of anxiety disorders: prevalence and societal costs
@en
P2093
Jean-Pierre Lépine
P478
63 Suppl 14
P577
2002-01-01T00:00:00Z